CEN/TS 18099 exposes the biometric injection validation gap

At a glance

What this is: This is an analysis of how CEN/TS 18099 changes biometric assurance by addressing injection attacks that presentation-attack testing does not cover.

Why it matters: It matters because identity teams cannot treat PAD results as proof of resistance to biometric injection, and procurement, assurance, and compliance decisions now need independent validation evidence.

Context

CEN/TS 18099 addresses a specific biometric governance gap: systems can be validated against presentation attacks and still remain unproven against injection attacks. In practice, that means a control can look complete on paper while leaving a different attack path untested.

For identity programmes, the issue is not biometric accuracy in the abstract. It is whether verification controls have been challenged by the right adversary method, under independent test conditions, and at a level that stands up to procurement and audit scrutiny.

The article frames injection resilience as a validation problem rather than a feature comparison. That is the right lens for IAM, because assurance depends on evidence that the control resists the attack mode it is supposed to stop.

Key questions

Q: What breaks when biometric systems are not tested against injection attacks and forged media?

A: When biometric systems are not tested for injection resistance, attackers can feed synthetic or manipulated media into the verification flow and bypass trust checks. The result is fraud, account takeover, and weak assurance at the point where identity evidence should be strongest. That failure undermines both security and compliance expectations.

Q: Why do organisations need independent validation for biometric injection resistance?

A: Because vendor-led testing is often proprietary and not comparable across solutions, which makes it weak as a procurement or audit input. Independent, standards-based validation gives teams a common evidentiary baseline and reduces the chance that assurance is built on claims that cannot be reproduced or benchmarked.

Q: How should organisations evaluate biometric controls for both spoofing and injection risk?

A: They should assess presentation attack detection and injection attack resilience separately, because the controls and test methods are different. A system that resists photos or masks may still fail when malicious data is inserted into the software path. Procurement should require independent evidence for both attack classes before the control is trusted in onboarding or step-up workflows.

Q: What should organisations ask before trusting biometric verification in identity programmes?

A: Ask which standard was used, which accredited lab performed the evaluation, and what level of resistance was demonstrated. If those details are missing, the claim is not independently verified in a way that supports high-confidence identity assurance or procurement approval.

Technical breakdown

Why presentation attack detection does not prove injection resilience

Presentation attack detection, or PAD, is designed to test whether a biometric system can reject visible spoofs such as photos, masks, and replayed video at the point of capture. Injection attacks are different because the adversary bypasses the camera-facing layer and manipulates the data path feeding the application. A system can therefore pass PAD and still accept synthetic or manipulated biometric input through software, emulator, or network-level injection. That is why ISO/IEC 30107 is necessary but not sufficient for modern biometric assurance. The control question shifts from whether a spoof is visible to whether the verification pipeline can be subverted upstream.

Practical implication: treat PAD certification as one evidence layer, not proof that biometric onboarding or authentication is injection-resistant.

How CEN/TS 18099 separates attack method from attack instrument

CEN/TS 18099 introduces a two-stage evaluation model. Injection Attack Method describes how the attack is delivered, such as hooking system functions, manipulating traffic, or using emulators. Injection Attack Instrument is the payload delivered through that path, such as a synthetic face or deepfake video. This distinction matters because some systems fail at the delivery stage while others fail only when malicious content reaches the verifier. By separating the pathway from the payload, the standard shows where the defensive boundary actually sits. That makes the result more useful for procurement, engineering, and risk decisions than a single pass or fail label.

Practical implication: ask vendors to show where the control stops the attack, at delivery, at payload inspection, or both.

Why independent lab validation matters more than vendor-led claims

Vendor-led testing often produces results that cannot be compared across solutions, especially when the methods are proprietary or the environment is non-production. Independent accreditation changes the evidentiary value because the lab, scope, and testing level are defined outside the vendor's own assumptions. In biometric assurance, that difference is decisive: if the test cannot be reproduced or benchmarked, it does not support defensible trust decisions. CEN/TS 18099 therefore matters not only as a standard, but as a common language for comparing resistance claims across suppliers and use cases.

Practical implication: require third-party, standards-based evidence before accepting biometric resistance claims in procurement or assurance reviews.

NHI Mgmt Group analysis

Biometric assurance now fails at the validation layer, not just the matcher layer. The article shows that a system can satisfy presentation-attack testing and still remain unproven against injection attacks. That is a governance failure because procurement teams may mistake one certification for end-to-end identity assurance. The practitioner conclusion is that biometric trust decisions must be anchored to the specific attack path being tested, not to generic fraud-resistance language.

CEN/TS 18099 gives the market a common evidentiary baseline for injection resilience. Proprietary lab claims and internal testing narratives are not comparable across vendors, so they do not support defensible risk decisions. A recognised standard changes the discussion from feature marketing to independently repeatable proof. The practitioner conclusion is that assurance teams should ask for the standard, the lab, and the test level before accepting biometric resilience claims.

Independent validation is now part of identity architecture, not an afterthought. Biometric verification sits inside broader digital identity assurance, so the question is whether the control can survive the adversary model the programme actually faces. CEN/TS 18099 aligns the evidence trail with that requirement and exposes where assurance programmes have been relying on untested assumptions. The practitioner conclusion is to treat biometric validation as a control boundary that must be proven, not presumed.

Injection resistance is becoming a procurement gate, not a technical footnote. When onboarding, fraud reduction, and compliance claims depend on biometrics, the absence of standards-based injection testing becomes a material sourcing risk. That shifts evaluation from product features to proof quality and comparability. The practitioner conclusion is that identity programmes should require independent lab evidence as a mandatory input to supplier selection and renewal.

Validation gaps create false confidence in identity programmes. If teams only test the threat they already know, they can end up certifying the wrong boundary. The article sharpens a useful named concept: biometric injection validation gap: the difference between passing presentation-attack tests and proving resistance to injected biometric data. The practitioner conclusion is to close that gap with standards-aligned evidence, not additional narrative.

What this signals

Biometric injection resilience is moving from a niche test case to an assurance requirement. Teams that rely on biometrics for onboarding or authentication need to distinguish between visible spoof resistance and proof that the attack path itself is blocked. The programme question is no longer whether biometrics work in controlled demos, but whether they remain trustworthy under the adversary methods that bypass the capture layer.

Biometric injection validation gap: this is the assurance gap that appears when a control has evidence for presentation attacks but no independent proof for injection attacks. Once that gap exists, security and compliance teams should stop treating biometric certification as a single binary and start requiring evidence matched to the threat path they actually face.

For practitioners

• Separate presentation and injection assurance Write procurement criteria that distinguish PAD evidence from injection attack resilience, and reject claims that collapse the two into one capability.
• Require independent lab proof Ask for the test standard, the accredited lab, and the evaluation level before accepting any biometric resistance claim in risk reviews.
• Map biometric testing to the threat path Check whether the control blocks attack delivery, detects malicious payloads, or only handles visible spoofs at the capture layer.
• Align assurance with NIST 800-63-4 expectations Use the identity assurance framework to decide which biometric evidence is sufficient for the use case, the risk level, and the trust boundary.

Key takeaways

• Biometric controls can pass presentation-attack testing and still fail to prove resistance to injection attacks that bypass the capture layer.
• The article's core evidence is that independent, standards-aligned validation changes the trust decision from assumption to proof.
• Organisations should separate spoof resistance from injection resilience and require accredited evidence before they rely on biometrics in identity assurance.

Key terms

• Presentation Attack: A presentation attack is an attempt to fool a biometric system with a fake face, replayed video, mask, or other synthetic artefact. In practice, the control fails when it measures resemblance alone, because the attacker’s objective is to pass as the real user without actually being that person.
• Injection attack: An attack that inserts synthetic or manipulated data directly into the verification flow rather than fooling the sensor itself. For identity programmes, this is a control-path problem, because the attacker may bypass the visible presentation layer and exploit the software decision point.
• Independent Validation: Independent validation is third-party testing against a recognised standard rather than a vendor's own test narrative. For identity controls, it gives procurement, audit, and security teams comparable evidence that a capability works against the specific threat model it claims to address.
• Biometric Identity Assurance: Biometric identity assurance is the use of physical or behavioural traits to verify that a person is who they claim to be. In practice, it is an evidence-producing control that supports authentication, auditability, and operational decision-making when high confidence is required.

Deepen your knowledge

NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building or maturing an IAM programme, it is worth exploring.